Filing search / Inhibrx Biosciences, Inc. / "Supply Chain"

DEFM14A

INBX Inhibrx Biosciences, Inc.

26 Apr 24

Proxy related to merger

4:06pm

or products in the supply chain for Company Products that involve payments in excess of $1,000,000 during the current fiscal year; A-18 (xviii

DEFA14A

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Additional proxy soliciting materials

6:38am

in the supply chain for Company Products that involve payments in excess of $1,000,000 during the current fiscal year; (xviii) is a hedging, derivative

8-K

EX-2.1

INBX Inhibrx Biosciences, Inc.

23 Jan 24

Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2B

6:35am

in the supply chain for Company Products that involve payments in excess of $1,000,000 during the current fiscal year; (xviii) is a hedging, derivative

10-K

5xz bmkfbvh

12 Mar 21

Annual report

8:46am

10-Q

0693t dwa9tftd8p6

13 Nov 20

Quarterly report

4:09pm

424B4

m5xi niqb3

19 Aug 20

Prospectus supplement with pricing info

5:21pm

DRS

x9lotjmw7tm9gkw18

26 Jun 20

Draft registration statement

12:00am